Get startedLog in
    Picture of Evonik Industries AG logo

    EVK — Evonik Industries AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    Basic MaterialsBalancedLarge CapNeutral
    All News

    Brief: Evonik Expands Lipid-Based Drug Delivery Capabilities With New Gmp Manufacturing Facility In Vancouver

    Picture of Evonik Industries AG logoEvonik Industries AG
    28/08/2026 08:02
    BRIEF-Evonik Expands Lipid-Based Drug Delivery Capabilities With New Gmp Manufacturing Facility In Vancouver
    Aug 28 (Reuters) - EVONIK INDUSTRIES AG EVKn.DE:
    • BASED DRUG DELIVERY CAPABILITIES WITH NEW GMP MANUFACTURING FACILITY IN VANCOUVER
    • INVESTS OVER CAD 150 MILLION (EUR 93 MILLION) IN NEW GMP FACILITY IN VANCOUVER
    • PROJECT SUPPORTED WITH UP TO CAD 68 MILLION (EUR 42 MILLION) FROM CANADIAN STRATEGIC RESPONSE FUND
    • DRUG PRODUCT PRODUCTION PLANNED TO BEGIN AT END OF 2029
    • LNP MARKET ESTIMATED TO REACH US$2.7 BILLION BY 2034
    Further company coverage: [EVKn.DE]

     (Gdansk Newsroom)
     ((Reuters Messaging: Gdansk.newsroom@thomsonreuters.com ; +48 58 7696600))

    Recent news on Evonik Industries AG

    See all news